Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Tokyo  >  ONO PHARMACEUTICAL CO., LTD.    4528   JP3197600004

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( JPY)
Sales 2017 297 336 M
EBIT 2017 -
Net income 2017 77 001 M
Finance 2017 129 348 M
Yield 2017 1,16%
Sales 2018 390 611 M
EBIT 2018 -
Net income 2018 114 500 M
Finance 2018 164 560 M
Yield 2018 1,55%
P/E ratio 2017 27,77
P/E ratio 2018 17,83
EV / Sales2017 7,44x
EV / Sales2018 5,57x
Capitalization 2 341 041 M
More Financials
Company
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of pharmaceutical and diagnostic reagents focusing on prescription pharmaceuticals.Its products include respiratory, digestive, urinary, chemotherapy, hormone, vitamins, and metabolic drugs.The company was founded by Ichibei... 
Sector
Pharmaceuticals
Calendar
08/02Earnings Release
More about the company
Surperformance© ratings of ONO PHARMACEUTICAL CO., LT
Trading Rating : Investor Rating :
More Ratings
Latest news on ONO PHARMACEUTICAL CO., LT
07/14 ONO PHARMACEUTICAL : Notice Concerning Determination of Details of Issuance of S..
07/11 CELYAD : and ONO strike deal for NKR-2 in Japan, Korea and Taiwan
07/11 CELYAD : SA Enters Licensing Agreement with ONO Pharma for NKR-2 T-cell Immunot..
07/11 ONO PHARMACEUTICAL : enters into license agreement with Celyad for its allogenei..
07/06 ONO PHARMACEUTICAL : European Commission approves ONGENTYS® (opicapone) a novel ..
07/04 ONO RECEIVES MANUFACTURING AND MARKE : Carfilzomib; development code: ONO-7057),..
06/29 ONO PHARMACEUTICAL : Notice Concerning Issuance of Stock Options (Stock Acquisit..
06/28 ONO PHARMACEUTICAL : Opdivo® (nivolumab) Receives Breakthrough Therapy Designati..
06/15 ONO PHARMACEUTICAL : New Data on Opdivo (nivolumab) Indicate Benefit in Heavily ..
06/09 ONO PHARMACEUTICAL : First Presentation of Phase 2 CheckMate-142 Study Evaluatin..
More news
Sector news : Generic Pharmaceuticals
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJJOHNSON & JOHNSON : Acclarent Unit in $18 Million U.S. Settlement
07/22DJBAYER : 2Q 2016 -- Forecast
07/22DJMonsanto Wins EU Nod for New Biotech Soybeans
07/21DJBIOGEN : Announces CEO Search, Lifts Guidance--2nd Update
More sector news : Generic Pharmaceuticals
Advertisement
Chart ONO PHARMACEUTICAL CO., LT
Duration : Period :
ONO PHARMACEUTICAL CO., LT Technical Analysis Chart | 4528 | JP3197600004 | 4-Traders
Full-screen chart
Technical analysis trends ONO PHARMACEUTICA...
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 5 668  JPY
Spread / Average Target 43%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Gyo Sagara President & Representative Director
Kazuhito Kawabata Director, Managing Executive Officer & GM-Research
Hiroshi Awata Director, EVP & General Manager-Development
Isao Ono Director & Managing Executive Officer
Kei Sano Director & GM-Corporate Administration
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ONO PHARMACEUTICAL CO...-8.03%22 039
SUN PHARMACEUTICAL IND..-3.80%28 176
OTSUKA HOLDINGS CO LTD15.96%26 399
BIOMARIN PHARMACEUTICA..-10.67%15 190
ASPEN PHARMACARE HOLDI..23.55%11 984
TAISHO PHARMACEUTICAL ..32.55%9 538
More Results